Literature DB >> 6217191

Expression of a Streptococcus mutans glucosyltransferase gene in Escherichia coli.

J P Robeson, R G Barletta, R Curtiss.   

Abstract

Chromosomal DNA from Streptococcus mutans strain UAB90 (serotype c) was cloned into Escherichia coli K-12. The clone bank was screened for any sucrose-hydrolyzing activity by selection for growth on raffinose in the presence of isopropyl-beta-D-thiogalactoside. A clone expressing an S. mutans glucosyltransferase was identified. The S. mutans DNA encoding this enzyme is a 1.73-kilobase fragment cloned into the HindIII site of plasmid pBR322. We designated the gene gtfA. The plasmid-encoded gtfA enzyme, a 55,000-molecular-weight protein, is synthesized at 40% the level of pBR322-encoded beta-lactamase in E. coli minicells. Using sucrose as substrate, the gtfA enzyme catalyzes the formation of fructose and a glucan with an apparent molecular weight of 1,500. We detected the gtfA protein in S. mutans cells with antibody raised against the cloned gtfA enzyme. Immunologically identical gtfA protein appears to be present in S. mutans cells of serotypes c, e, and f, and a cross-reacting protein was made by serotype b cells. Proteins from serotype a, g, and d S. mutans cells did not react with antibody to gtfA enzyme. The gtfA activity was present in the periplasmic space of E. coli clones, since 15% of the total gtfA activity was released by cold osmotic shock and the clones were able to grow on sucrose as sole carbon source.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217191      PMCID: PMC217359          DOI: 10.1128/jb.153.1.211-221.1983

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  40 in total

1.  Inhibition of avian sarcoma virus replication by glucosamine: a specific effect on the synthesis and processing of viral proteins.

Authors:  M J Hayman; E Hunter; P K Vogt
Journal:  Virology       Date:  1976-06       Impact factor: 3.616

2.  Regulation and extracellular glucosyltransferase production and the relationship between extracellular and cell-associated activities in Streptococcus mutans.

Authors:  W M Janda; H K Kuramitsu
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

3.  Low sucrose levels promote extensive Streptococcus mutans-induced dental caries.

Authors:  S M Michalek; J R McGhee; T Shiota; D Devenyns
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Escherichia coli pleiotropic mutant that reduces amounts of several periplasmic and outer membrane proteins.

Authors:  B L Wanner; A Sarthy; J Beckwith
Journal:  J Bacteriol       Date:  1979-10       Impact factor: 3.490

5.  Characterization of extracellular glucosyltransferase activity of Steptococcus mutans.

Authors:  H K Kuramitsu
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

6.  Immunological relationships between glucosyltransferases from Streptococcus mutans serotypes.

Authors:  H Kuramitsu; L Ingersoll
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Streptococcus mutans dextransucrase: availability of disaggregated enzyme after growth in a chemically defined medium.

Authors:  C F Schachtele; S K Harlander; G R Germaine
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

8.  Tryptophan-transducing bacteriophages: in vitro studies with restriction endonucleases HindII + III and Escherichia coli ribonucleic acid polymerase.

Authors:  B B Jones; W S Reznikoff
Journal:  J Bacteriol       Date:  1977-10       Impact factor: 3.490

9.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

10.  Antigenic relatedness of glucosyltransferase enzymes from streptococcus mutans.

Authors:  D J Smith; M A Taubman
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

View more
  39 in total

1.  Cloning of sucrase operon with mini-Mu and plasmid-mediated metabolism of sucrose.

Authors:  J Grones; M Macor; V Bilská
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

2.  Impairment of melibiose utilization in Streptococcus mutans serotype c gtfA mutants.

Authors:  R G Barletta; R Curtiss
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Nucleotide sequence of a glucosyltransferase gene from Streptococcus sobrinus MFe28.

Authors:  J J Ferretti; M L Gilpin; R R Russell
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

4.  Sequence analysis of the gtfB gene from Streptococcus mutans.

Authors:  T Shiroza; S Ueda; H K Kuramitsu
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

Review 5.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

6.  Cloning and expression of two Streptococcus mutans glucosyltransferases in Escherichia coli K-12.

Authors:  M L Gilpin; R R Russell; P Morrissey
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Recent advances in defining the cariogenicity of mutans streptococci: molecular genetic approaches.

Authors:  H K Kuramitsu
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

Review 8.  Role of Streptococcus mutans in human dental decay.

Authors:  W J Loesche
Journal:  Microbiol Rev       Date:  1986-12

9.  Expression of Mycobacterium leprae genes from a Streptococcus mutans promoter in Escherichia coli K-12.

Authors:  W R Jacobs; M A Docherty; R Curtiss; J E Clark-Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Inactivation of the Streptococcus mutans wall-associated protein A gene (wapA) results in a decrease in sucrose-dependent adherence and aggregation.

Authors:  H Qian; M L Dao
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.